Authors: Kalff, V Hicks, RJ MacManus, MP Binns, DS McKenzie, AF Ware, RE Hogg, A Ball, DL

Citation: V. Kalff et al., Clinical impact of F-18 fluorodeoxyglucose positron emission tomography inpatients with non-small-cell lung cancer: A prospective study, J CL ONCOL, 19(1), 2001, pp. 111-118

Authors: Hicks, RJ Kalff, V MacManus, MP Ware, RE Hogg, A McKenzie, AF Matthews, JP Ball, DL

Citation: Rj. Hicks et al., F-18-FDG PET provides high-impact and powerful prognostic stratification in staging newly diagnosed non-small cell lung cancer, J NUCL MED, 42(11), 2001, pp. 1596-1604

Authors: Hicks, RJ Kalff, V MacManus, MP Ware, RE McKenzie, AF Matthews, JP Ball, DL

Citation: Rj. Hicks et al., The utility of F-18-FDG PET for suspected recurrent non-small cell lung cancer after potentially curative therapy: Impact on management and prognostic stratification, J NUCL MED, 42(11), 2001, pp. 1605-1613

Authors: Pitman, AG Hicks, RJ Kalff, V Binns, DS Ware, RE McKenzie, AF Ball, DL MacManus, MP

Citation: Ag. Pitman et al., Positron emission tomography in pulmonary masses where tissue diagnosis isunhelpful or not possible, MED J AUST, 175(6), 2001, pp. 303-307